openPR Logo
Press release

Investigation announced for Investors in shares of Vaxart, Inc. (NASDAQ: VXRT)

07-27-2020 06:21 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Vaxart, Inc. (NASDAQ: VXRT) shares over potential securities laws violations by Vaxart, Inc.

An investigation for investors in Vaxart, Inc. (NASDAQ: VXRT) shares over potential securities laws violations by Vaxart, Inc.

Vaxart, Inc is under investigation over possible securities laws violations in connection with certain financial statements.

Investors who purchased shares of Vaxart, Inc. (NASDAQ: VXRT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Vaxart, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Francisco, CA based Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. Vaxart, Inc. reported that its annual Total Revenue rose from $4.15 million in 2018 to $9.86 million in 2019, and that its Net Loss increased from $18 million in 2018 to $18.64 million in 2019.

Shares of Vaxart, Inc. (NASDAQ: VXRT) rose from $0.36 per share in January 2020 to as high as $17.15 per share on July 16, 2020.

Since then shares of Vaxart, Inc. (NASDAQ: VXRT) declined to $12.00 per share on July 24, 2020.

Those who purchased shares of Vaxart, Inc. (NASDAQ: VXRT) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Vaxart, Inc. (NASDAQ: VXRT) here

News-ID: 2097473 • Views: 534

More Releases from Shareholders Foundation

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Alert: Investigation over pot …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vanda Pharmaceuticals Inc. (NASDAQ: VNDA. Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those Vanda Pharmaceuticals Inc. (NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Vanda Pharmaceuticals Inc. (NASDAQ: VNDA
Investigation announced for Long-Term Investors in shares of Milestone Pharmaceu …
Certain directors of Milestone Pharmaceuticals Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) and currently hold any of those NASDAQ: MIST shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Milestone Pharmaceuticals directors breached their fiduciary duties and caused damage to the
Investigation announced for Long-Term Investors in shares of iQIYI, Inc. (NASDAQ …
An investigation was announced for investors in shares of iQIYI, Inc. (NASDAQ: IQ) concerning potential breaches of fiduciary duties by certain directors and officers of iQIYI, Inc.. Investors who are current long term investors in iQIYI, Inc. (NASDAQ: IQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IQ
Investigation announced for Investors in shares of Noble Energy, Inc. (NASDAQ: N …
An investigation was announced concerning whether the takeover of Noble Energy, Inc.is unfair to: NBL stockholders. Investors who purchased shares of Noble Energy, Inc. (NASDAQ: NBL) and currently hold any of those NASDAQ: NBL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Noble Energy, Inc. breached their fiduciary duties

All 5 Releases


More Releases for Vaxart

Vaccines Delivery Market In-Depth Analysis Report 2019| Becton Dickinson and Com …
The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Vaccines Delivery market. It sheds light on how the global Vaccines Delivery Market is expected to grow during the course of the forecast period. With SWOT analysis and Porter’s Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Vaccines Delivery market and different
Oral Vaccines Market 2019: by Top Key Players Vaxart, Immunitor, PaxVax, Prokari …
This recently published report examines the Global Oral Vaccines market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Oral Vaccines market along with its drivers, restraints, and trends. It also classifies the market into different segments such
Oral Vaccines Market Cost Structure & Future Demands including key players : Vax …
Latest research study from HTF MI with title Global and United States Oral Vaccines by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type, application/end-users. The research study provides estimates for Global and United
Global Marburg Hemorrhagic Fever Drug Market 2018 - GlaxoSmithKline plc, Immunov …
Apex Market Reports, recently published a detailed market research study focused on the “Marburg Hemorrhagic Fever Drug Market” across the global, regional and country level. The report provides 360° analysis of “Marburg Hemorrhagic Fever Drug Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend
Global Vaccines Delivery Market Size, Status and Forecast 2025 : BioCSL, Novavax …
Qyresearchreports include new market research report "Global Vaccines Delivery Market Size, Status and Forecast 2025" to its huge collection of research reports. The report that has been compiled to describe the Vaccines Delivery market, also acts as a valuable insight for businesses who wish to grow in this industry. The report extensively outlines important factors that such as geographical reach, factors contributing towards better sales, dominant segments, amidst many others. Businesses
Global Vaccines Delivery Market 2018 - BioCSL, Novavax Inc., Vaxart Inc.
Global Vaccines Delivery Market 2018 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Vaccines Delivery piece of the overall industry and Growth patterns, concentrating on driving Vaccines Delivery industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2025. The major regions present in the continents like United States, Germany, Japan and China and their contribution to global Vaccines Delivery market is